RayzeBio被BMS 41亿美元收购,用于扩充差异化平台和管线 Gallery

RayzeBio被BMS 41亿美元收购,用于扩充差异化平台和管线

Vivo Capital’s Portfolio Company IO Biotech Announces an IPO Gallery

Vivo Capital’s Portfolio Company IO Biotech Announces an IPO

Vivo Capital’s Portfolio Company Aadi BioSceince announced a FDA approval of FYARRO for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) Gallery

Vivo Capital’s Portfolio Company Aadi BioSceince announced a FDA approval of FYARRO for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)

Vivo Capital, Co-Leads a $75m Series A Round of Financing in Ablaze Pharmaceuticals Gallery

Vivo Capital, Co-Leads a $75m Series A Round of Financing in Ablaze Pharmaceuticals

Vivo Capital, Leads a $200m Series A Round of Financing in Avistone Pharmaceuticals Gallery

Vivo Capital, Leads a $200m Series A Round of Financing in Avistone Pharmaceuticals

Legend Biotech Announces FDA Approval of CARVYKTI Gallery

Legend Biotech Announces FDA Approval of CARVYKTI